Palatin LeuTech Diagnostic Cost-Effectiveness Analysis Under Way
This article was originally published in The Gray Sheet
Executive Summary
Palatin Technologies is conducting a cost effectiveness analysis to support use of LeuTech to aid in the diagnosis of equivocal appendicitis.